Statement from Binita Ashar, M.D., of the FDA ’ s Center for Devices and Radiological Health on agency ’ s continuing efforts to educate patients on known risk of lymphoma from breast implants

Statement from Binita Ashar, M.D., of the FDA ’ s Center for Devices and Radiological Health on agency ’ s continuing efforts to educate patients on known risk of lymphoma from breast implants
Source: Food and Drug Administration - Category: American Health Source Type: news